We provide biological research and development services, focusing on drug discovery, molecular research
and bioninformatics. We perform compound testing, enzyme testing, assay development, computational
biochemistry and data analysis from trials. We convert our data and discoveries into ready to use programs
for testing, manufacturing and patents. We provide integrated scientific services that support clients from
early-stage research through to advanced analytical evaluation.
Our work spans target exploration, assay development, data interpretation, and customized research
solutions tailored to diverse scientific and industrial needs. We aim to enable faster, more reliable progress
in developing new therapies and understanding biological systems at a deeper level.
We operate as a collaborative partner to biotech firms, pharmaceutical companies, and academic
institutions. Our multidisciplinary team ensures high-quality outcomes through precision and transparency.
With a strong focus on innovation and ethical responsibility, we continuously refine our methods to meet
evolving research challenges. Our goal is to deliver impactful science that drives meaningful advancements
in healthcare and technology.
We are committed to our partners and clients through transparent communication, reliable scientific expertise, and consistent delivery of high-quality results. We prioritize trust, collaboration, and responsiveness, ensuring that every project aligns with their goals and contributes to meaningful, successful outcomes. By maintaining open dialogue, understanding evolving needs, and applying rigorous scientific standards, we build long-term relationships that support innovation, drive efficiency, and ensure sustained success across diverse research and development initiatives.
Contact Us
Biomedical Engineering Society
Biotechnology Innovation Organization
Good Laboratory Practice (GLP)
International Organization for Standardization
Society of Biology Engineering
American Society for Microbiology
International Organization for Standardization
Our biotechnology research and engineering capabilities are strengthened through connections with
respected scientific and professional organizations across the life sciences. Affiliations with the
American Society for Microbiology (ASM), Biomedical Engineering Society (BMES),
Biotechnology Innovation Organization (BIO), and Society for Biological Engineering (SBE) help
keep our team connected with developments across biotechnology, biological engineering,
microbiology, biomedical research, and emerging scientific technologies. These relationships
complement our multidisciplinary approach to laboratory research, technical analysis, process
development, and biotechnology engineering while supporting continued professional development
and engagement with the broader scientific community.
Recognized standards and structured practices are equally important to the way we conduct and
manage technical work. Good Laboratory Practice (GLP) principles support disciplined laboratory
activities and dependable research documentation, while ISO 14971 risk management principles
inform applicable biotechnology and biomedical development projects. Our ISO/IEC 27001
Information Security Management System further supports the protection of sensitive research
information, technical documentation, intellectual property, and client data. Together, these
professional affiliations and established frameworks demonstrate a commitment to scientific
integrity, responsible research practices, information security, and consistently high standards
throughout our biotechnology engineering and R&D activities.
Knowledgeshift was founded in 2012. Soon, we became inspired by the opportunity to translate our insights
into life-changing medicines, prompting us to establish our own drug discovery capabilities and pursue
collaborations with multiple biopharmaceutical companies. We expanded our expertise into cell and
molecular biology services, bioinformatics and data analysis, testing and analytics, custom research projects,
and preclinical research.
These capabilities allowed us to generate deeper biological understanding and support efficient therapeutic
innovation across different sectors. They also enabled us to offer more customized R&D solutions to our
clients, strengthening our ability to address complex scientific challenges and deliver meaningful, highquality outcomes.